About
Merck Kgaa (XETRA:MRK) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
Apr 1 2026
MilliporeSigma Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio
Feb 6 2026
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
Jan 20 2026
Merck and ChemLex Sign Memorandum of Understanding to Advance Automated Chemistry and Technological Innovation
Jan 12 2026
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
Financials
Revenue
€21.1 B
Market Cap
€47.74 B
P/E Ratio
18.30
EPS
6.00
Dividend Yield
2.00%
Translate